| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | United States | 4 | |
| #4 | Australia | 3 | |
| #5 | Canada | 3 | |
| #6 | Hong Kong | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nanchahal Jagdeep | 20 |
| #2 | Feldmann Marc | 19 |
| #3 | Larsen Glenn R | 11 |
| #4 | Larsen Glenn | 11 |
| #5 | Glenn Larsen | 2 |
| #6 | Jagdeep Nanchahal | 2 |
| #7 | Marc Feldmann | 2 |
| #8 | 180 Therapeutics Lp | 1 |
| #9 | Feldman Marc | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3506920A1 | Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody | |
| US2019225682A1 | Method of treating localized fibrotic disorders using an il-33/tnf bispecific antibody | |
| WO2017177021A1 | Method of treating early stage dupuytren's disease | |
| WO2016140921A1 | Method of treating a localized fibrotic disorder using an il-33 antagonist | |
| WO2015006469A2 | Method of treating fibroproliferative disorders with human matrix metalloproteinase and a tnf antagonist |